NEW YORK (AP) ¿ A UBS analyst said Wednesday that medical technology stocks are trading at attractive prices, and raised his ratings or price targets on nine of them. Analyst Bruce Nudell upgraded shares of medical device maker Boston Scientific Corp. and orthopedic implant maker Zimmer Holdings Inc. to "buy" from "neutral." He said stock prices throughout the sector should improve as expectations on health care reform become more concrete and less negative. Nudell raised his price target on Zimmer shares to $64 from $59, and his price target on Boston Scientific to $10 per share from $9.50. Zimmer stock rose $1.24, or 2.2 percent, to close at $57.99. Earlier, shares of the Warsaw, Ind., company set an annual high of $58.18. Shares of Boston Scientific, which is based in Natick, Mass., rose 12 cents to $8.39. The analyst also raised his target on Abbott Laboratories, to $61 per share from $57 per share; Baxter International Inc., to $64 per share from $62 per share; Edwards Lifesciences Corp., to $90 per share from $89 per share; Johnson & Johnson, to $70 per share from $67 per share; Medtronic Inc., to $50 per share from $49 per share; St. Jude Medical Inc., to $42 per share from $40 per share; and Stryker Corp., to $59 per share from $58 per share.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Investing
Replay: Jim Cramer Tackles Trump's Tweets, the Fed and Facebook's 'Libra'
Jim Cramer breaks down the Fed drift ahead of Wednesday's announcement, Facebook's Libra whitepaper, and shares three stocks that he's keeping a close eye on.
A Deeply Undervalued Dividend Stock From the North
With its high dividend yield, Manulife investors are paid well to be patient.
Rep. Maxine Waters Calls for Moratorium on Facebook's Libra Currency
U.S. lawmakers voiced concerns about Facebook'c cryptocurrency initiative, dubbed Libra.
July 4th Sale: Join Jim Cramer's Club for Investors and Save
Get 57% off on your membership to Jim's Action Alerts PLUS club for investors.